Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELND005 as Adjunctive Maintenance Treatment in Bipolar I Disorder
NCT01674010Phase 2Terminated
- Sponsor
- OPKO Health
- Start
- Aug 2012
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 2 trial of scyllo-inositol in bipolar I disorder, sponsored by OPKO Health. Started Aug 2012; status: terminated.
02
Drugs
scyllo-inositol
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT01674010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01674010.